1117 GMT - Tate & Lyle gave an overall mixed update, leading Goodbody to consider lowering its top-of-the-range fiscal 2026 Ebitda estimate by mid-single digits, analyst Patrick Higgins says. The U.K. provider of food-and-drink ingredients noted tariff uncertainty on exports from the U.S. to China, expecting an around 3% foreign exchange rate headwind. While the update is unlikely to be a positive catalyst, Higgins retains his positive stance on the stock, saying that it has strong mid-term growth potential. The initial delivery through the integration of CP Kelco has so far been encouraging, with full combined operational benefits to come through from fiscal 2027 onward, he says. Shares trade 3.8% lower at 580 pence. (nina.kienle@wsj.com)

(END) Dow Jones Newswires

May 22, 2025 07:17 ET (11:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.